Overexpression of CCL2 in the tumor epithelium correlates with tumor grade and poor patient prognosis in various tumor types including: gliomas, prostate cancers, ovarian cancers and breast cancers [17, 18]. The gene discussed is CCL2; the disease is breast cancer.